- •The doctor is online – and on webcam
- •Smoking cartoon characters to be cured of their bad habits
- •The Moscow news
- •Police seize large batch of fake flu medicine
- •Poisonous smoke in Moscow cafes
- •Health minister invents new medical treatment, again
- •Russia sanitary chief warns of anthrax epidemic
- •Vet’s jail-sentence over animal anesthetic upheld
- •Hiv activists protest over drug pricing policy
- •Demands to make drug use a criminal offence
- •Airlines permitted to ban the disabled if the plane is not properly equipped
- •Medvedev calls for nationwide smoking ban
- •Medics with a mission
- •It’s not easy living green
- •Skolkovo joins fight against cancer
- •Shops, companies fighting alcohol and tobacco bans
- •Biomedicine on the catwalk
- •Student job to career
- •Greenpeace looking to public
- •Altai pipeline stirs ecology fears
- •Modernization on the march
- •An obscure industry struggles for growth
- •Battling ignorance and saving lives
- •Blood lines The Moscow News
- •Russia’s medical tourism up, but domestic industry in need
- •The Moscow News
- •Israel a top location
- •Russia’s medical tourism up, but domestic industry in need
- •The Moscow News
- •Fines for smoking in public in Russia take effect
- •The Moscow News
- •Russians drink 25% less than before – health official
- •The Moscow News
- •143,000 Russians killed by hiv-related illnesses – official
- •The Moscow News
- •Hiv infection rate in Russia has grown 7% this year
- •The Moscow News
- •Russian cancer treatment centers: Where to go
- •The Moscow News
- •Health group fights fat with free salads on Moscow metro
- •The Moscow News
- •The Moscow News
- •Prisoners of the psyche: Forced psychiatry in today’s Russia
- •The Moscow News
- •New hiv strain in Russia spreading rapidly – scientists
- •The Moscow News
- •The Moscow News
- •Russian icUs: death behind closed doors
- •The Moscow News
- •Abortion: a matter of life and death
- •The Moscow News
- •"Problems of Regionalizing the Program "Drug Provision for High-Cost Diseases" and Civilian Control in Health Care"
- •Lower House passes bill on rights of disabled people
- •The Moscow News
- •Health Ministry defends adoptions by hiv-positive people
- •The Moscow News
- •Parents should not be barred from Russian children’s hospitals
- •The Moscow News
- •Russia ready to step up fight against China bird flu
- •The Moscow News
- •They’re right here: Autism in Russia
- •The Moscow News
- •Tuberculosis deaths down in Moscow, but infections increase
- •The Moscow News
- •Russian deputy proposes garlic ban
- •The Moscow News
- •The Moscow News
- •Russian watchdog digs up more horsemeat
- •The Moscow News
- •Russia vs. Fake drugs: an international threat
- •The Moscow News
- •Putin signs anti-smoking bill into law
- •The Moscow News
- •Russia bloggers slam kids drug test quiz as guide for addicts
- •The Moscow News
- •Puff, puff, pass a smoking ban
- •The Moscow News
- •Moscow airports face tightened flu control
- •The Moscow News
- •Moscow to foot bill for drug tests on youth
- •The Moscow News
- •St. Petersburg cancer center to stay: health minister
- •The Moscow News
- •Smoking room in Duma to close
- •The Moscow News
- •Russian doctors troubled by growing tb infection rate
- •The Moscow News
- •Migrants to undergo drug tests - Russia's Chief Narcologist
- •The Moscow News
- •Paid ambulances in state hospitals illegal – activist
- •The Moscow News
- •New Year holidays are a week of horror – chief doctor
- •The Moscow News
- •Report hits Russia’s lapses in counterfeit drugs fight
- •The Moscow News
- •Lawmakers to ban doctors from ads
- •The Moscow News
- •Russian health folklore and ‘cure’ for the common cold
- •The Moscow News
- •Rugby at Luzhniki: Russia’s new love
- •The Moscow News
- •Duma deputy wants permanent winter time for Russia
- •The Moscow News
- •Russia says Latvia sprats contain high levels of carcinogens
- •The Moscow News
- •Russian male smokers complain of impotence warnings
- •The Moscow News
- •143,000 Russians killed by hiv-related illnesses – official
- •The Moscow News
Skolkovo joins fight against cancer
by Oleg Nikishenkov at 10/11/2011
The Moscow News
The Skolkovo Foundation is pushing ahead in the race to find a cure to cancer, awarding three biopharmaceutical startups grants this week to conduct research at the innovation hub near Moscow.
The three ventures, Asinex Medchem, Fusion Pharma and NewVac, focus on alternative methods to curing the often fatal disease at an advanced stage by localizing cancerous cells using inhibitors.
The grants are part of the Skolkovo Foundation’s drive to turn the hub into a leading world player in the innovation sector. Also this week, the fund announced plans to boost funding in startup projects in partnership with U.S. Software giant Microsoft.
Fusion Pharma General Director Ghermes Chilov told The Moscow News that the funding provided by Skolkovo, along with separate funding from an unnamed “big Russian pharmaceutical company,” would help the India-based firm take its research to the clinical testing stage.
The firm has developed a way of using computer software to simulate molecules that can enter a cancerous growth and destroy it. Chilov said the computer-generated molecules were capable of curing even highly resistant strains of cancer.
“With our technology we were able to conduct the necessary tests with just 20 synthesized molecules, while it takes thousands to get to this stage of tests with current technologies,” Chilov said.
Igor Goryanin, head of the Skolkovo biomedical cluster and a professor at Edinburgh University told The Moscow News on the sidelines of a startup event in Moscow on Tuesday that the Invitro network of independent medical laboratories found that the cancer inhibitors made by Fusion Pharma in Russia were more effective than any others the firm has built.
President Medvedev meeting with young entrepreneurs at Skolkovo
Biomedicine is one of the key fields of research at the Skolkovo hub and the cluster, which is being developed in cooperation with the Baker and McKenzie international consultancy, has chosen oncology as a top priority in terms of its commercialization perspectives.
Goryanin said that Skolkovo coordinated its cancer treatment program with the Russian Health Ministry, which has named lung cancer as the number one cancer threat for Russia.
“According to the Ministry’s latest research, 90 percent of all patients who are diagnosed with the disease die within a year,” Goryanin said.
NewVac, one of the other firms that was awarded Skolkovo funding, uses research developed by Russian medical scientist Mikhail Sitkovsky, who has spent the past 20 years working in the United States.
The Russian-based firm has developed medicines for fighting cancer’s resistance to destruction by the human immune system, which it presented to the Kremlin’s modernization commission earlier this year.
Medvedev told the commission that if NewVac’s research is successful, it would be “a revolution in history of the fight against the cancer” and will allow the Skolkvovo project to be considered a success.
Although one of NewVac’s oncologic vaccines has already been registered with the U.S. Food and Drug Administration, Sitkovsky told the commission that the company welcomes the Skolkovo funding since it is becoming increasingly difficult to obtain sponsorship in the United States.
The third company to be awarded funding on Tuesday, Asinex Medchem, has invented special molecules that can enter the human brain and destroy brain cancer cells.
“Our brain has a special cellular defense barrier, which does not let alien substances get inside, and medicine is also an alien substance for it. But our medicine can bypass this defense,” Deputy Director Denis Kazyulkin told The Moscow News.
3146